• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种能在体内与BRCA1基因产物相互作用的环状蛋白的鉴定。

Identification of a RING protein that can interact in vivo with the BRCA1 gene product.

作者信息

Wu L C, Wang Z W, Tsan J T, Spillman M A, Phung A, Xu X L, Yang M C, Hwang L Y, Bowcock A M, Baer R

机构信息

Department of Microbiology, University of Texas Southwestern Medical Center, Dallas 75235, USA.

出版信息

Nat Genet. 1996 Dec;14(4):430-40. doi: 10.1038/ng1296-430.

DOI:10.1038/ng1296-430
PMID:8944023
Abstract

The hereditary breast and ovarian cancer gene, BRCA1, encodes a large polypeptide that contains the cysteine-rich RING motif, a zinc-binding domain found in a variety of regulatory proteins. Here we describe a novel protein that interacts in vivo with the N-terminal region of BRCA1. This BRCA1-associated RING domain (BARD1) protein contains an N-terminal RING motif, three tandem ankyrin repeats, and a C-terminal sequence with significant homology to the phylogenetically conserved BRCT domains that lie near the C terminus of BRCA1. The BARD1/BRCA1 interaction is disrupted by BRCA1 missense mutations that segregate with breast cancer susceptibility, indicating that BARD1 may be involved in mediating tumour suppression by BRCA1.

摘要

遗传性乳腺癌和卵巢癌基因BRCA1编码一种大型多肽,该多肽含有富含半胱氨酸的RING基序,这是一种在多种调节蛋白中发现的锌结合结构域。在此,我们描述了一种在体内与BRCA1的N端区域相互作用的新型蛋白质。这种与BRCA1相关的RING结构域(BARD1)蛋白含有一个N端RING基序、三个串联的锚蛋白重复序列,以及一个C端序列,该序列与BRCA1 C端附近系统发育保守的BRCT结构域具有显著同源性。BARD1/BRCA1相互作用被与乳腺癌易感性相关的BRCA1错义突变破坏,这表明BARD1可能参与介导BRCA1的肿瘤抑制作用。

相似文献

1
Identification of a RING protein that can interact in vivo with the BRCA1 gene product.一种能在体内与BRCA1基因产物相互作用的环状蛋白的鉴定。
Nat Genet. 1996 Dec;14(4):430-40. doi: 10.1038/ng1296-430.
2
Conservation of function and primary structure in the BRCA1-associated RING domain (BARD1) protein.BRCA1相关的环状结构域(BARD1)蛋白中功能和一级结构的保守性。
Oncogene. 1998 Oct 22;17(16):2143-8. doi: 10.1038/sj.onc.1202123.
3
Binding and recognition in the assembly of an active BRCA1/BARD1 ubiquitin-ligase complex.活性BRCA1/BARD1泛素连接酶复合物组装中的结合与识别
Proc Natl Acad Sci U S A. 2003 May 13;100(10):5646-51. doi: 10.1073/pnas.0836054100. Epub 2003 May 5.
4
Structure of a BRCA1-BARD1 heterodimeric RING-RING complex.一种BRCA1 - BARD1异二聚体RING - RING复合物的结构。
Nat Struct Biol. 2001 Oct;8(10):833-7. doi: 10.1038/nsb1001-833.
5
Structural requirements for the BARD1 tumor suppressor in chromosomal stability and homology-directed DNA repair.BARD1肿瘤抑制因子在染色体稳定性和同源性指导的DNA修复中的结构要求。
J Biol Chem. 2007 Nov 23;282(47):34325-33. doi: 10.1074/jbc.M705198200. Epub 2007 Sep 11.
6
Nuclear-cytoplasmic shuttling of BARD1 contributes to its proapoptotic activity and is regulated by dimerization with BRCA1.BARD1的核质穿梭作用有助于其促凋亡活性,并受与BRCA1二聚化的调控。
Oncogene. 2004 Mar 11;23(10):1809-20. doi: 10.1038/sj.onc.1207302.
7
Identification of an apoptotic cleavage product of BARD1 as an autoantigen: a potential factor in the antitumoral response mediated by apoptotic bodies.鉴定BARD1的一种凋亡裂解产物作为自身抗原:凋亡小体介导的抗肿瘤反应中的一个潜在因素。
Cancer Res. 2000 Dec 15;60(24):6895-900.
8
Mapping the functional domains of BRCA1. Interaction of the ring finger domains of BRCA1 and BARD1.绘制BRCA1的功能结构域。BRCA1和BARD1的环状结构域之间的相互作用。
J Biol Chem. 1999 Feb 26;274(9):5659-65. doi: 10.1074/jbc.274.9.5659.
9
The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation.环状异二聚体BRCA1-BARD1是一种因乳腺癌衍生突变而失活的泛素连接酶。
J Biol Chem. 2001 May 4;276(18):14537-40. doi: 10.1074/jbc.C000881200. Epub 2001 Mar 6.
10
Interactions between BRCT repeats and phosphoproteins: tangled up in two.BRCT重复序列与磷酸化蛋白之间的相互作用:纠结于二者之中。
Trends Biochem Sci. 2004 Nov;29(11):579-85. doi: 10.1016/j.tibs.2004.09.010.

引用本文的文献

1
Pathogenic Mutations Disrupt Allosteric Control by .致病突变破坏了由……引起的变构调控。
J Phys Chem B. 2025 Aug 7;129(31):7922-7931. doi: 10.1021/acs.jpcb.5c03653. Epub 2025 Jul 29.
2
Multi-omics Characterization of Acquired Olaparib Resistance in BRCA1 and BRCA2 Mutant Breast Cancer Cell Lines.BRCA1和BRCA2突变乳腺癌细胞系中获得性奥拉帕尼耐药性的多组学特征分析
Mol Cell Proteomics. 2025 Jul 14;24(8):101034. doi: 10.1016/j.mcpro.2025.101034.
3
Pathogenic mutations disrupt allosteric control by .致病突变破坏了由……引起的变构调控。
bioRxiv. 2025 Jun 10:2025.06.07.658438. doi: 10.1101/2025.06.07.658438.
4
BRCA1 and BRCA2 as prognostic markers in oral squamous cell carcinoma: a minireview.BRCA1和BRCA2作为口腔鳞状细胞癌的预后标志物:一篇综述。
Front Oncol. 2025 Mar 28;15:1528822. doi: 10.3389/fonc.2025.1528822. eCollection 2025.
5
Computational studies on the functional and structural impact of pathogenic mutations in enzymes.酶中致病突变对功能和结构影响的计算研究。
Protein Sci. 2025 Apr;34(4):e70081. doi: 10.1002/pro.70081.
6
The Emerging Role of the Histone H2AK13/15 Ubiquitination: Mechanisms of Writing, Reading, and Erasing in DNA Damage Repair and Disease.组蛋白H2AK13/15泛素化的新作用:DNA损伤修复和疾病中“书写”“读取”及“擦除”机制
Cells. 2025 Feb 18;14(4):307. doi: 10.3390/cells14040307.
7
BRCA1 and BRCA2: from cancer susceptibility to synthetic lethality.BRCA1和BRCA2:从癌症易感性到合成致死性
Genes Dev. 2025 Jan 7;39(1-2):86-108. doi: 10.1101/gad.352083.124.
8
The role of RAD51 regulators and variants in primary ovarian insufficiency, endometriosis, and polycystic ovary syndrome.RAD51调控因子及变异体在原发性卵巢功能不全、子宫内膜异位症和多囊卵巢综合征中的作用
NAR Mol Med. 2024 Sep 28;1(4):ugae010. doi: 10.1093/narmme/ugae010. eCollection 2024 Oct.
9
FLT1 activation in cancer cells promotes PARP-inhibitor resistance in breast cancer.在癌细胞中激活 FLT1 可促进乳腺癌对 PARP 抑制剂的耐药性。
EMBO Mol Med. 2024 Aug;16(8):1957-1980. doi: 10.1038/s44321-024-00094-2. Epub 2024 Jul 2.
10
Genomic Characterization of Preclinical Prostate Cancer Cell Line Models.临床前前列腺癌细胞系模型的基因组特征分析。
Int J Mol Sci. 2024 Jun 1;25(11):6111. doi: 10.3390/ijms25116111.